These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26102527)

  • 21. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.
    Ying SY; Fang W; Lin SL
    Methods Mol Biol; 2018; 1733():283-304. PubMed ID: 29435941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of Pluripotent Stem Cells Using Somatic Cell Nuclear Transfer and Induced Pluripotent Somatic Cells from African Green Monkeys.
    Chung YG; Seay M; Elsworth JD; Redmond DE
    Stem Cells Dev; 2020 Oct; 29(19):1294-1307. PubMed ID: 32715987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
    Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells.
    Ji H; Zhang X; Oh S; Mayhew CN; Ulm A; Somineni HK; Ericksen M; Wells JM; Khurana Hershey GK
    J Allergy Clin Immunol; 2015 Jan; 135(1):236-44. PubMed ID: 25441642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chimpanzee and pig-tailed macaque iPSCs: Improved culture and generation of primate cross-species embryos.
    Roodgar M; Suchy FP; Nguyen LH; Bajpai VK; Sinha R; Vilches-Moure JG; Van Bortle K; Bhadury J; Metwally A; Jiang L; Jian R; Chiang R; Oikonomopoulos A; Wu JC; Weissman IL; Mankowski JL; Holmes S; Loh KM; Nakauchi H; VandeVoort CA; Snyder MP
    Cell Rep; 2022 Aug; 40(9):111264. PubMed ID: 36044843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs).
    Ma N; Shan Y; Liao B; Kong G; Wang C; Huang K; Zhang H; Cai X; Chen S; Pei D; Chen N; Pan G
    J Biol Chem; 2015 May; 290(19):12079-89. PubMed ID: 25795783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection via pluripotency-related transcriptional screen minimizes the influence of somatic origin on iPSC differentiation propensity.
    Hartjes KA; Li X; Martinez-Fernandez A; Roemmich AJ; Larsen BT; Terzic A; Nelson TJ
    Stem Cells; 2014 Sep; 32(9):2350-9. PubMed ID: 24802033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights from a chimpanzee adipose stromal cell population: opportunities for adult stem cells to expand primate functional genomics.
    Pfefferle LW; Wray GA
    Genome Biol Evol; 2013; 5(10):1995-2005. PubMed ID: 24092797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do Induced Pluripotent Stem Cell Characteristics Correlate with Efficient In Vitro Smooth Muscle Cell Differentiation? A Comparison of Three Patient-Derived Induced Pluripotent Stem Cell Lines.
    Zhou Y; Kang G; Wen Y; Briggs M; Sebastiano V; Pederson R; Chen B
    Stem Cells Dev; 2018 Oct; 27(20):1438-1448. PubMed ID: 30153084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Many human accelerated regions are developmental enhancers.
    Capra JA; Erwin GD; McKinsey G; Rubenstein JL; Pollard KS
    Philos Trans R Soc Lond B Biol Sci; 2013 Dec; 368(1632):20130025. PubMed ID: 24218637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status.
    Awe JP; Lee PC; Ramathal C; Vega-Crespo A; Durruthy-Durruthy J; Cooper A; Karumbayaram S; Lowry WE; Clark AT; Zack JA; Sebastiano V; Kohn DB; Pyle AD; Martin MG; Lipshutz GS; Phelps PE; Pera RA; Byrne JA
    Stem Cell Res Ther; 2013 Jul; 4(4):87. PubMed ID: 23890092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs.
    Chen J; Liu H; Liu J; Qi J; Wei B; Yang J; Liang H; Chen Y; Chen J; Wu Y; Guo L; Zhu J; Zhao X; Peng T; Zhang Y; Chen S; Li X; Li D; Wang T; Pei D
    Nat Genet; 2013 Jan; 45(1):34-42. PubMed ID: 23202127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining differentially methylated regions specific for the acquisition of pluripotency and maintenance in human pluripotent stem cells via microarray.
    He W; Kang X; Du H; Song B; Lu Z; Huang Y; Wang D; Sun X; Yu Y; Fan Y
    PLoS One; 2014; 9(9):e108350. PubMed ID: 25250679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs.
    Zhao MT; Chen H; Liu Q; Shao NY; Sayed N; Wo HT; Zhang JZ; Ong SG; Liu C; Kim Y; Yang H; Chour T; Ma H; Gutierrez NM; Karakikes I; Mitalipov S; Snyder MP; Wu JC
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11111-E11120. PubMed ID: 29203658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity.
    Steichen C; Luce E; Maluenda J; Tosca L; Moreno-Gimeno I; Desterke C; Dianat N; Goulinet-Mainot S; Awan-Toor S; Burks D; Marie J; Weber A; Tachdjian G; Melki J; Dubart-Kupperschmitt A
    Stem Cells Transl Med; 2014 Jun; 3(6):686-91. PubMed ID: 24736403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primate iPS cells as tools for evolutionary analyses.
    Wunderlich S; Kircher M; Vieth B; Haase A; Merkert S; Beier J; Göhring G; Glage S; Schambach A; Curnow EC; Pääbo S; Martin U; Enard W
    Stem Cell Res; 2014 May; 12(3):622-9. PubMed ID: 24631741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.